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Elicits Both "Early" and "Late" Delayed
Hypersensitivity Skin Reactions'
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Lepromin is a preparation of killed My-
cobacterium leprae of human or armadillo
origin, and it is used extensively for the as-
sessment of delayed-type hypersensitivity
(DTH) against M. leprae. After intradermal
injection of lepromin, two types ofskin DTH
responses are seen in people who are sen-
sitized: an "early" (Fernandez) reaction
which peaks at 24-48 hr and a "late" (Mit-
suda) reaction which peaks at 3-4 weeks ('7).
The late lepromin reaction has shown a
strong correlation with immunity to my-
cobacterial infections in both experimental
animals (2) and humans (5). However, the
integrity of bacterial morphology in a lep-
romin preparation appears to be essential
for the development of a late reaction. Ul-
trasonically disrupted lepromin or the sol-
uble extract of M. leprae (leprosin) elicit only
the early reaction (22.23). There are specu-
lations that the soluble antigen(s) may also
produce a late reaction, provided the anti-
gen is presented in the same manner as that
of intact Al. leprae (' 7 22). To investigate this
possibility, we have used soluble antigen(s)
of M. leprae (23) coupled with liposome as
a skin-test antigen, hoping that such a sys-
tem would mimic the antigen presentation
by intact bacilli.
MATERIALS AND METHODS
All of the chemicals and reagents used in
this study were of the highest purity avail-
able. Egg lecithin was prepared as described
earlier (21). Gangliosidcs were isolated from
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buffalo brain using the known method (13).
Cholesterol was purchased from Centron
Research Laboratory, Bombay, India, and
crystallized three times from methanol. So-
dium cyanoborohydride was from Sigma
Chemical Company, St. Louis, Missouri,
U.S.A. Sodium ' 25I-iodide (carrier-free) was
bought from Bhabha Atomic Research
Centre, Trombay, India.
M. leprae soluble antigen(s). Soluble an-
tigen(s) of M. leprae, prepared by the de-
scribed method (23), was kindly provided by
Dr. R. J. W. Rees, Clinical Research Centre,
Harrow, U.K. Briefly, M. leprae purified
from infected armadillo tissues (25) were ul-
trasonically disrupted before ultracentrifu-
gation (105,000 x g x 30 min). The su-
pernatant, termed "leprosin-A," was used
after protein estimation (14).
'25I-labeling of the soluble antigen(s). Fif-
ty mg protein of the soluble antigen(s) (in 50
/21) was labeled with ' 25 I using the "Iodogen"
technique (7). More than 95% of the radio-
activity was incorporated in the protein peak
recovered after Sephadex G-25 gel filtra-
tion.
Preparation of liposomes. Unilamellar li-
posomes were prepared from egg lecithin
(45 AM), cholesterol (45 MM), and ganglio-
sides (9 ktIvI) in 2.0 ml borate-buffered saline
(10 mM borate containing 60 mM NaC1,
pH 8.4) by probe-type sonication and frac-
tionated by ultracentrifugation, as described
earlier (").
Covalent coupling of liposomes with an-
tigen(s). The soluble protein of Al. leprae
was covalently coupled to the liposome sur-
face according to the method of Heath, et
al. (")). Briefly, liposomes were oxidized with
sodium periodate (2 lir, 25-30°C, dark). The
excess reagent was removed by gel filtration,
and the liposome fractions, after pooling to-
gether, were concentrated to about 1 ml (5—
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THE TABLE. Early (48 In) and late (3
weeks) skin reactions with different antigen
preparations in borderline tuberculoid lep-
rosy patients.
Patient Reaction LA L'' LP' L2' L3'• 0'
1 Early 29' 28 30 28 28 0
Late 0 10 10 10 0
Early 20 25 3/ /6 27 <5
Late o 7 9 9 7 0
3 Early 28 22 ND' 46 3/ <5
Late 0 0 ND 0 0 0
4 Early 0 0 ND 13 15 <5
Late 0 6 ND 9 0 0
5 Early 23 18 ND 27 30 <5
Late 0 0 ND 0 0 0
6 Early 12 12 ND 15 13 0
Late 0 0 ND 0 0 0
7 Early 15 P ND 14 12 0
Late () 5 ND 8 5 0
8 Early /6 24 ND "73 27 0
Late 0 12 ND 10 6 0
9 Early 30 22 ND 20 19 0
Late 0 5 ND 10 10 0
10 Early 18 16 ND 16 14 0
Late 0 5 ND 7 6 0
" LA = leprosin-A (10 pg/ml).
L = Dharmendra lepromin (107 bacilli/m1).
L1-3 = liposomized leprosin-A at 40, 20, and 10
pg protein/ml.
C = control liposomes.
' Indurations in mm.
ND = not determined.
7 AM lipid), as described earlier (20). To it
were added the unlabeled Al. leprae anti-
gen(s) (about 8 mg), '21-labeled antigen(s)
(=50,000 cpm), and sodium cyanoboro-
hydride (2 M, 10 pl/m1). The mixture was
incubated at 25-30°C for 14-16 hr. It was
chromatographed on a Scpharose 6B col-
umn (1.4 x 35 cm) using phosphate-buff-
ered saline (10 mM phosphate containing
150 M NaC1, pH 7.4; PBS) as the eluant.
The liposomes were recovered in the void
volume. Under these conditions, 18-20%
(=1.5 mg unlabeled protein or =10,000
cpm) of the protein initially added got cross-
linked to the liposome surface. The lipo-
some-rich fractions were pooled together,
dialyzed against sterile PBS, and filtered
through a Millipore membrane (0.2 rim). A
preparation of control liposomes was also
subjected to the above-mentioned antigen
coupling steps, in the absence of antigen.
Testing of antigen-coupled liposomes. The
antigen-coupled liposomes were diluted to
10, 20, and 40 pg protein/ml sterile PBS
and used for skin testing. Simultaneously,
control liposomes (free of antigen), Dhar-
mendra lepromin (''), and leprosin-A (23)
were also tested. All of the preparations were
coded and tested by a clinician (GR) in a
double-blind manner. Ten borderline tu-
berculoid (BT) and five lepromatous (LL)
leprosy patients ('s) attending the outpatient
department and wards of Central JALMA
Institute of Leprosy (CJIL), Agra, India, were
selected kir the study. The test preparations
were injected intradermally (0.1 ml each)
into the back of every patient. The diame-
ters of the skin indurations (mean of two
readings at right angles to each other) were
recorded in millimeters with the help of a
vernier scale at 48 hr and 21 days. An in-
duration of 5 mm or more was regarded as
positive in the case of the 48-hr (early) re-
action and that or 4 mm or more was re-
garded as positive for the 21-day (late) re-
action ("). Biopsy specimens representing
the early (48 hr) and late (21 day) skin re-
actions to the liposome-coupled antigen
were fixed in Zenker-formol saline, pro-
cessed, and embedded in paraffin. Five-pm
sections were stained with hematoxylin and
eosin (H&E). The sections were examined
by a pathologist without referring to the case
notes to avoid personal bias.
RESULTS
The Table depicts the skin reactions in
10 BT patients at 48 hr (early) and at 21
days (late) elicited by the different antigen
preparations and controls. While leprosin-A
(LA) elicited only the early reaction, Dhar-
mendra lepromin (L) elicited early, late, or
both early and late reactions. In two patients
tested initially, all three concentrations of
liposomized leprosin elicited strong reac-
tions. In subsequent patients, the use of the
highest concentration (LI) was omitted. In
all of these patients, liposomized antigen
elicited early and late skin reactions akin to
those elicited by Dharmendra lepromin, ex-
cept in one patient who was early-reaction
negative with Dharmendra lepromin but
positive with liposomized antigen. Control
liposomes induced insignificant reactions at
48 hr in four patients.
The 48-hr skin reaction elicited by lipo-
somized leprosin showed a histological pic-
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FIG. 1. Photomicrograph of 48-hr reaction of a 13T
case showing lymphocyte and polymorphonuclear in-
filtration (H&E x 1200).
FIG. 2. Photomicrograph of 21-day reaction of a
BT case showing lymphocytes, epithelioid cells, and
giant cells in the infiltrate (H&E x 1200).
lure of DTH, with a predominant lympho-
cytic infiltration. Polymorphonuclear cells
were present to a lesser extent (Fig. 1). The
21-day reaction to the liposomized antigen
showed a histological picture resembling a
tuberculoid granuloma with focal collec-
tions of epithelioid and giant cells (Fig. 2).
None of the live LL patients showed any
positive skin reaction to these antigens.
DISCUSSION
Several studies have shown that the im-
munogenicity of antigens is improved by
incorporating them in liposomes C). It has
also been demonstrated that this action of
liposomes is further enhanced when antigen
is covalently attached on their surface (24).
These observations prompted us to cova-
lently couple soluble Al. leprae antigen(s)
(leprosin) to liposomes, and then to deter-
mine whether the liposome-coupled anti-
gen(s) could elicit both the early and late
skin DTH responses.
The results of this study support the
working hypothesis that the presentation of
eliciting antigen(s) in a specific orientation
is required for the development of late re-
actions. In the method of Heath, et al. (")
which we used, protein molecules are co-
valently linked with the liposome surface
due to a reaction between the amino groups
of the proteins and the aldehyde groups of
the ganglioside via the formation of Schiff's
bases. In the present situation, it seems that
such a linkage does not adversely affect the
antigenicity of the attached proteins. Ap-
parently the liposomes presented surface-
bound protein antigens to the host cells in
the specific manner of intact Al. leprae and
thus activated the lymphoid cell precursors
which were responsible for the development
of the late skin-test reaction.
The cells may not require the continued
presence of the stimulus for the develop-
ment of late reactions, since we know that
liposomes are rapidly disintegrated in vivo
('). For the same reason, the adjuvant effect
of liposomes may not be operational in the
development of the late reaction. Moreover,
in a separate study, when the liposome-en-
trapped leprosin was used for skin testing
or BT patients it did not produce the late
reaction although the early reaction was
elicited (data not shown). Both early and
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late reactions to the liposome-coupled an-
tigen showed histological pictures corre-
sponding to the reactions elicited by integral
lepromin (4).
The early reaction elicited by control li-
posomes in some of the cases is not signif-
icant, since an early reaction of <5 mm is
not regarded as positive (".23).
On the basis of the present study, it is not
possible to define the molecule(s) involved
in the development of the DTH reactions.
The decision to use whole (unfractionated)
soluble antigen was made because studies
so far have led to diverse conclusions re-
garding the physicochemical properties of
the DTH-eliciting antigens of Al. leprae or
even any other mycobacterium (3). More-
over, studies on Al. leprae are limited due
to non-availability of the organisms in suf-
ficient quantities. The major source of M.
leprae remains the experimentally infected
nine-banded armadillo (9. Recently, iso-
lation of molecularly defined Al. leprae an-
tigens has been made possible with the help
of monoclonal antibodies (6) and gene clon-
ing (26). Such preparations would be those
of choice for future work using liposomes.
There is experimental evidence to suggest
that the late (21 day) DTH reaction is a
marker for protective immunity against
multibacillary mycobacterial infections (2.5).
Since the Al. leprae antigen covalently linked
with liposomes is capable of eliciting the late
reaction, liposome may serve as a carrier
and immunopotentiator of activity of mo-
lecularly defined, cell-mediated immunity-
inducing antigens of Ai. leprae which are
presently being evolved (14. 15).
SUMMARY
The soluble antigen(s) of Mycobacterium
leprac was(were) coupled to liposomes and
used for skin testing of leprosy patients,
hoping that this mode of antigen presenta-
tion would be identical to that of integral
lepromin. The liposomized antigen(s) elic-
ited both early (24-48 hr) and late (3-4
weeks) delayed-type hypersensitivity reac-
tions, true to the nature of lepromin, unlike
the soluble antigen(s) alone which elicit(s)
only the early reaction.
RESUMEN
Sc incorporaron antigenos solubles de .tiycobucte-
rium leprae a liposomas y Sc usaron para pruebas en
piel en pacientes con lepra esperando que este modo
de presentaciOn del antigen° pudiera ser identico al de
la lepromina integral. Los antigenos incluidos en los
liposomas, indujeron tanto las reacciones de hipersen-
sibilidad retardada tempranas (24-48 h) como las tar-
dias (3-4 semanas), en tanto que los ant igenos solubles
solos nada to indujeron la reacciOn temprana.
RESUME
On a couple l'antigene ou les antigenes de M yco-
bac teri u m leprae n des liposomes pour pratiquer des
epreuves cutanees chez des malades de la lepre, dans
l'espoir de demontrer que cc mode de presentation
antigenique serait identique a celui de la lepromine
integrale. L'antigene ou les antigenes wit entrain& des
reactions precoces apres 24 it 48 heures, et des reac-
tions tardives du type d'hypersensibilite retardee apres
3 et 4 semaines, comme c'est le cas apres injection de
lepromine, alors que l'antigene on les antigenes so-
lublcs administres scuts Wont entrain& qu'une reaction
precoce.
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